It has been reported that the levels of serum biomarkers correlate with lower back pain and related functional impairment [40], and that the severity of polyneuropathy is associated with elevated tumor necrosis factor-alpha and interleukin-6 (IL-6) [41]. This evidence concerns the gene IL6 and polyneuropathy.